Pioneering a health care innovation ecosystem to better serve patients
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
Collaboration with pharmaceutical giant will bring smart jet-injection device to market.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Red, green, and blue light can be used to control gene expression in engineered E. coli.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Seed funding from the MIT Sandbox Innovation Fund helped Multiply Labs' founders launch their personalized dietary supplement startup.
Automated manufacturing could make it easier to develop and test new peptide drugs.
From EpiPen pricing to government oversight, the making of medicine impacts all aspects of modern health care.
Kristala Jones Prather engineers microbes to produce compounds that can be used in industrial processes efficiently and economically.
MIT International Science and Technology Initiatives (MISTI) matches MIT students to internships with corporate partners around the world.
Model indicates that diverse research approaches to the disease would be a rewarding investment.
Stephen Miles helps to bring the benefits of serialized identification systems to translational medicine and research.
Ram Sasisekharan’s startups provide novel methods to fight disease and make better drugs.
Chemists devise a new way to manufacture peptide drugs, which hold promise for treating many diseases.